ID22074A - Senyawa-senyawa baru dengan efek analgesik - Google Patents

Senyawa-senyawa baru dengan efek analgesik

Info

Publication number: ID22074A
Authority: ID; Indonesia
Prior art keywords: new compounds; analgesic effects; analgesic; effects; compounds
Prior art date: 1996-12-20

Application number

IDW990508A

Other languages

English (en)

Indonesian (id)

Inventor

Daniel Delorme

Edward Roberis

Zhongyong Wei

Original Assignee

Astra Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-09

Publication date

1999-09-02

1996-12-20 Priority claimed from SE9604785A external-priority patent/SE9604785D0/xx

1997-07-01 Priority claimed from SE9702535A external-priority patent/SE9702535D0/xx

1997-12-09 Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc

1999-09-02 Publication of ID22074A publication Critical patent/ID22074A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

IDW990508A 1996-12-20 1997-12-09 Senyawa-senyawa baru dengan efek analgesik ID22074A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604785A SE9604785D0 (sv)	1996-12-20	1996-12-20	New compounds
SE9702535A SE9702535D0 (sv)	1997-07-01	1997-07-01	New compounds

Publications (1)

Publication Number	Publication Date
ID22074A true ID22074A (id)	1999-09-02

Family

ID=26662830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990508A ID22074A (id)	1996-12-20	1997-12-09	Senyawa-senyawa baru dengan efek analgesik

Country Status (29)

Country	Link
US (5)	US6187792B1 (fr)
EP (1)	EP0946511B1 (fr)
JP (1)	JP4324652B2 (fr)
KR (1)	KR100549144B1 (fr)
CN (2)	CN1146540C (fr)
AR (1)	AR010376A1 (fr)
AT (1)	ATE296288T1 (fr)
AU (1)	AU737999B2 (fr)
BR (1)	BR9714055B1 (fr)
CA (1)	CA2274074C (fr)
CZ (1)	CZ295557B6 (fr)
DE (1)	DE69733362T2 (fr)
EE (1)	EE03824B1 (fr)
ES (1)	ES2241060T3 (fr)
HK (1)	HK1022689A1 (fr)
HU (1)	HU226724B1 (fr)
ID (1)	ID22074A (fr)
IL (2)	IL130535A0 (fr)
IS (1)	IS2210B (fr)
MY (1)	MY119403A (fr)
NO (1)	NO313670B1 (fr)
NZ (1)	NZ336029A (fr)
PL (1)	PL189196B1 (fr)
PT (1)	PT946511E (fr)
RU (1)	RU2193029C2 (fr)
SK (1)	SK283211B6 (fr)
TR (1)	TR199901417T2 (fr)
TW (1)	TW548271B (fr)
WO (1)	WO1998028275A1 (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
US6436959B1 (en)	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides
US6677332B1 (en)	1999-05-25	2004-01-13	Sepracor, Inc.	Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en)	1999-05-25	2008-04-22	Sepracor, Inc.	Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en)	2000-05-25	2003-10-21	Sepracor Inc.	Heterocyclic analgesic compounds and methods of use thereof
JP2003500392A (ja) *	1999-05-25	2003-01-07	セプラコール，インク．	複素環式鎮痛性化合物およびその使用方法
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
US6306876B1 (en)	1999-12-22	2001-10-23	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
WO2001060796A1 (fr) *	2000-02-18	2001-08-23	Meiji Seika Kaisha, Ltd.	DERIVES DE PHENOXYALKYLAMINE UTILES EN TANT QU'AGONISTES DU RECEPTEUR OPIOIDE $g(d)
CN1426411A (zh)	2000-03-03	2003-06-25	奥索-麦克尼尔药品公司	3－(二芳基亚甲基)－8－氮杂双环[3.2.1]辛烷衍生物
AU4274401A (en)	2000-03-24	2001-10-03	Meiji Seika Kaisha	Diphenylalkylamine derivatives useful as opioid delta receptor agonists
SE0001208D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
SE0001209D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
SE0001207D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
WO2001092226A1 (fr)	2000-05-25	2001-12-06	Sepracor, Inc.	Composes analgesiques heterocycliques et technique d'utilisation de ceux-ci
AU2002234010A1 (en)	2000-12-14	2002-06-24	Ortho-Mcneil Pharmaceutical, Inc.	Benzamidine derivatives
BR0209678A (pt)	2001-05-18	2004-09-14	Astrazeneca Ab	Composto, processo para preparar e uso do mesmo, composição farmacêutica, e, métodos para o tratamento da dor e de distúrbios gastrintestinais funcionais
SE0101768D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101770D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101767D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101773D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101765D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101771D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101769D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101766D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0103313D0 (sv) *	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
PL367967A1 (en)	2001-10-15	2005-03-07	Janssen Pharmaceutica N.V.	Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
TW200301701A (en)	2002-01-02	2003-07-16	Ardent Pharmaceuticals Inc	Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US8476280B2 (en) *	2002-05-09	2013-07-02	Versi Group, Llc	Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
UA77536C2 (en) *	2002-07-03	2006-12-15	Lundbeck & Co As H	Secondary aminoaniline piperidines as mch1 antagonists and their use
SE0203301D0 (sv) *	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0300104D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300105D0 (sv) *	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv)	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300987D0 (sv) *	2003-04-03	2003-04-03	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EP1615920A1 (fr) *	2003-04-15	2006-01-18	Pfizer Products Inc.	Derives de 3-benzhydrylidene-8-aza-bicyclo [3.2.1]octane a activite de recepteur d'opioides
SE0301443D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301441D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301445D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301442D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
MXPA05012117A (es) *	2003-05-16	2006-02-08	Astrazeneca Ab	Derivados de diarilmetiliden piperidina, preparaciones de los mismos y usos de los mismos.
EP1626044A4 (fr)	2003-05-20	2008-08-20	Ajinomoto Kk	Nouveau derive de piperidine
CA2530444C (fr)	2003-06-27	2012-03-13	Janssen Pharmaceutica, N.V.	Modulateurs du recepteur opioide tricycliques
WO2005012220A2 (fr)	2003-07-28	2005-02-10	Smithkline Beecham Corporation	Composes chimiques
JP4976134B2 (ja)	2003-10-01	2012-07-18	アドラーコーポレーション	スピロ環複素環誘導体及びそれらを使用する方法
SE0400025D0 (sv) *	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400026D0 (sv) *	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
US7435822B2 (en)	2004-02-03	2008-10-14	Janssen Pharmaceutica N.V.	3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
KR101234421B1 (ko)	2004-08-02	2013-02-18	아스트라제네카 아베	디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
AU2005335481A1 (en)	2004-08-05	2007-04-19	Janssen Pharmaceutica N.V.	Tricyclic delta- opioid modulators
SE0402485D0 (sv) *	2004-10-13	2004-10-13	Astrazeneca Ab	Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt
KR20070092293A (ko)	2004-12-22	2007-09-12	얀센 파마슈티카 엔.브이.	트리사이클릭 δ-오피오이드 모듈레이터
BRPI0519201A2 (pt)	2004-12-22	2008-12-30	Janssen Pharmaceutica Nv	moduladores de delta-opiàide tricÍclico
EP1846400A2 (fr)	2005-01-06	2007-10-24	Janssen Pharmaceutica N.V.	Modulateurs delta-opioide tricycliques
US7557875B2 (en)	2005-03-22	2009-07-07	Industrial Technology Research Institute	High performance flexible display with improved mechanical properties having electrically modulated material mixed with binder material in a ratio between 6:1 and 0.5:1
US7683168B2 (en) *	2005-04-14	2010-03-23	Mount Cook Bio Sciences, Inc.	Compositions of novel opioid compounds and method of use thereof
WO2006138528A2 (fr)	2005-06-16	2006-12-28	Janssen Pharmaceutica N.V	Modulateurs d'opioides tricycliques
US7576207B2 (en)	2006-04-06	2009-08-18	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
CN105748175A (zh) *	2006-09-06	2016-07-13	史密夫和内修有限公司	带有过渡表面的植入物和相关的方法
MY148880A (en) *	2006-10-20	2013-06-14	Astrazeneca Ab	N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
CA2707455A1 (fr) *	2007-12-06	2009-06-11	Shell Internationale Research Maatschappij B.V.	Procede de preparation d'alkylene glycol
KR20180014745A (ko) *	2015-06-02	2018-02-09	코닝 인코포레이티드	에스테틱 표면 및 그 에스테틱 표면을 갖는 디스플레이 장치
CN111825654A (zh) *	2019-04-19	2020-10-27	北京酷瓴生物技术有限公司	苯甲烯哌啶衍生物及其制备方法、中间体和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2898339A (en) *	1957-07-29	1959-08-04	Wm S Merrell Co	N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) *	1983-07-27	1986-04-08	Janssen Pharmaceutica, N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4816586A (en) *	1987-07-29	1989-03-28	Regents Of The University Of Minnesota	Delta opioid receptor antagonists
US5140029A (en) *	1989-01-09	1992-08-18	Janssen Pharmaceutica N.V.	2-aminopyrimidinone derivatives
US4939137A (en) *	1989-06-28	1990-07-03	Ortho Pharmaceutical Corporation	Ring-fused thienopyrimidinedione derivatives
US5683998A (en) *	1991-04-23	1997-11-04	Toray Industries, Inc.	Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
US5574159A (en) *	1992-02-03	1996-11-12	Delta Pharmaceuticals, Inc.	Opioid compounds and methods for making therefor
GB9202238D0 (en)	1992-02-03	1992-03-18	Wellcome Found	Compounds
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
TW548271B (en) *	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
CA2316341A1 (fr)	1997-12-24	1999-07-08	Ortho-Mcneil Pharmaceutical, Inc.	(4)-aryl(piperidine-4-yl) aminobenzamides se liant au recepteur opioide delta
SE0001207D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
SE0001208D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds

1997
- 1997-12-08 TW TW086118465A patent/TW548271B/zh not_active IP Right Cessation
- 1997-12-09 ID IDW990508A patent/ID22074A/id unknown
- 1997-12-09 CN CNB971818142A patent/CN1146540C/zh not_active Expired - Fee Related
- 1997-12-09 EE EEP199900256A patent/EE03824B1/xx not_active IP Right Cessation
- 1997-12-09 CN CNB2004100082366A patent/CN100519528C/zh not_active Expired - Fee Related
- 1997-12-09 CA CA002274074A patent/CA2274074C/fr not_active Expired - Fee Related
- 1997-12-09 PT PT97950538T patent/PT946511E/pt unknown
- 1997-12-09 TR TR1999/01417T patent/TR199901417T2/xx unknown
- 1997-12-09 IL IL13053597A patent/IL130535A0/xx active IP Right Grant
- 1997-12-09 KR KR1019997005585A patent/KR100549144B1/ko not_active IP Right Cessation
- 1997-12-09 HU HU0000610A patent/HU226724B1/hu not_active IP Right Cessation
- 1997-12-09 AU AU53512/98A patent/AU737999B2/en not_active Ceased
- 1997-12-09 WO PCT/SE1997/002050 patent/WO1998028275A1/fr active IP Right Grant
- 1997-12-09 JP JP52866998A patent/JP4324652B2/ja not_active Expired - Fee Related
- 1997-12-09 EP EP97950538A patent/EP0946511B1/fr not_active Expired - Lifetime
- 1997-12-09 BR BRPI9714055-4A patent/BR9714055B1/pt not_active IP Right Cessation
- 1997-12-09 AT AT97950538T patent/ATE296288T1/de not_active IP Right Cessation
- 1997-12-09 ES ES97950538T patent/ES2241060T3/es not_active Expired - Lifetime
- 1997-12-09 CZ CZ19992199A patent/CZ295557B6/cs not_active IP Right Cessation
- 1997-12-09 RU RU99115750/04A patent/RU2193029C2/ru not_active IP Right Cessation
- 1997-12-09 PL PL97334374A patent/PL189196B1/pl not_active IP Right Cessation
- 1997-12-09 DE DE69733362T patent/DE69733362T2/de not_active Expired - Lifetime
- 1997-12-09 US US09/029,633 patent/US6187792B1/en not_active Expired - Lifetime
- 1997-12-09 NZ NZ336029A patent/NZ336029A/en unknown
- 1997-12-09 SK SK762-99A patent/SK283211B6/sk not_active IP Right Cessation
- 1997-12-19 AR ARP970106074A patent/AR010376A1/es active IP Right Grant
- 1997-12-19 MY MYPI97006173A patent/MY119403A/en unknown
1999
- 1999-06-07 IS IS5071A patent/IS2210B/is unknown
- 1999-06-17 IL IL130535A patent/IL130535A/en not_active IP Right Cessation
- 1999-06-18 NO NO19993022A patent/NO313670B1/no not_active IP Right Cessation
2000
- 2000-03-11 HK HK00101528A patent/HK1022689A1/xx not_active IP Right Cessation
2001
- 2001-01-18 US US09/761,833 patent/US6455545B2/en not_active Expired - Fee Related
2002
- 2002-08-19 US US10/222,990 patent/US6693117B2/en not_active Expired - Fee Related
2003
- 2003-12-09 US US10/730,265 patent/US7312336B2/en not_active Expired - Fee Related
2007
- 2007-12-05 US US11/951,014 patent/US20080176903A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EE9900256A (et)	1999-12-15
NZ336029A (en)	2001-03-30
SK76299A3 (en)	1999-11-08
IL130535A0 (en)	2000-06-01
AU5351298A (en)	1998-07-17
HUP0000610A3 (en)	2000-10-30
CN1146540C (zh)	2004-04-21
NO993022L (no)	1999-08-20
US20040171612A1 (en)	2004-09-02
US6693117B2 (en)	2004-02-17
CZ219999A3 (cs)	1999-11-17
BR9714055A (pt)	2000-05-09
PL189196B1 (pl)	2005-07-29
IS2210B (is)	2007-02-15
MY119403A (en)	2005-05-31
PT946511E (pt)	2005-09-30
HK1022689A1 (en)	2000-08-18
TW548271B (en)	2003-08-21
CA2274074C (fr)	2006-07-11
IS5071A (is)	1999-06-07
NO313670B1 (no)	2002-11-11
NO993022D0 (no)	1999-06-18
IL130535A (en)	2006-04-10
WO1998028275A1 (fr)	1998-07-02
RU2193029C2 (ru)	2002-11-20
JP4324652B2 (ja)	2009-09-02
ES2241060T3 (es)	2005-10-16
DE69733362T2 (de)	2006-02-02
HUP0000610A2 (hu)	2000-09-28
SK283211B6 (sk)	2003-03-04
CN1246111A (zh)	2000-03-01
AR010376A1 (es)	2000-06-07
HU226724B1 (en)	2009-08-28
TR199901417T2 (xx)	1999-10-21
EE03824B1 (et)	2002-08-15
BR9714055B1 (pt)	2010-02-23
DE69733362D1 (de)	2005-06-30
US20010021715A1 (en)	2001-09-13
KR100549144B1 (ko)	2006-02-03
ATE296288T1 (de)	2005-06-15
EP0946511A1 (fr)	1999-10-06
CN1524852A (zh)	2004-09-01
JP2001507350A (ja)	2001-06-05
KR20000069599A (ko)	2000-11-25
AU737999B2 (en)	2001-09-06
US20080176903A1 (en)	2008-07-24
US6455545B2 (en)	2002-09-24
PL334374A1 (en)	2000-02-28
CZ295557B6 (cs)	2005-08-17
US6187792B1 (en)	2001-02-13
CN100519528C (zh)	2009-07-29
US20030149023A1 (en)	2003-08-07
CA2274074A1 (fr)	1998-07-02
EP0946511B1 (fr)	2005-05-25
US7312336B2 (en)	2007-12-25

Publication	Publication Date	Title
ID22074A (id)	1999-09-02	Senyawa-senyawa baru dengan efek analgesik
ID21662A (id)	1999-07-08	Senyawa-senyawa baru dengan efek analgesik
ID16420A (id)	1997-09-25	Komposisi farmasi baru dengan efek anastesia
EE9800194A (et)	1998-12-15	Uued valuvaigistava toimega ühendid
ID21881A (id)	1999-08-05	Turunan-turunan baru pirazol tersubstitusi
ID17686A (id)	1998-01-22	Fotoinisiator alpha-aminoasetofenon baru
PT799819E (pt)	2003-01-31	Compostos de 1-dimetilaminometil-2-fenilcicloalc-2-eno com efeito analgesico
ID15840A (id)	1997-08-14	Turunan-turunan 19-nor-pregnena baru
DE59810166D1 (de)	2003-12-18	Analgetika-kombination
ID18431A (id)	1998-04-09	Senyawa-senyawa baru
ID16660A (id)	1997-10-30	Senyawa-senyawa b-laktam monosiklik baru
ID18262A (id)	1998-03-19	Turunan-turunan baru piranosida
EE9800195A (et)	1998-12-15	Uudsed analgeetilise toimega ühendid
ID19433A (id)	1998-07-09	Senyaw-senyawa baru
ID16684A (id)	1997-10-30	Senyawa-senyawa sulfonilurea baru
ID22144A (id)	1999-09-09	Senyawa-senyawa baru
ID18889A (id)	1998-05-20	Senyawa baru
ID16373A (id)	1997-09-25	Senyawa-senyawa baru
ID17265A (id)	1997-12-18	Herbisida-herbisida baru
ID19545A (id)	1998-07-23	Herbisida baru
ID16813A (id)	1997-11-13	Herbisida-herbisida baru
SE9603470D0 (sv)	1996-09-23	New compounds
SE9604787D0 (sv)	1996-12-20	New compounds
SE9603505D0 (sv)	1996-09-25	New compounds
SE9604785D0 (sv)	1996-12-20	New compounds